Acute toxic epidermal necrolysis reaction post single dose pembrolizumab with preceding cephalosporin exposure: successful rechallenge with anti-PD-1 therapy

Intern Med J. 2019 Aug;49(8):1051-1053. doi: 10.1111/imj.14388.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Antibodies, Monoclonal, Humanized / toxicity*
  • Cephalosporins / therapeutic use
  • Female
  • Humans
  • Melanoma / drug therapy*
  • Skin / pathology
  • Stevens-Johnson Syndrome / etiology*
  • Stevens-Johnson Syndrome / pathology

Substances

  • Antibodies, Monoclonal, Humanized
  • Cephalosporins
  • pembrolizumab